RFK Jr. & claimed regenerative peptides like BPC 157 The Niche BPC 157 FDA approval status 2026: Is it legal? Veedma Peptides are starting to move back into the conversation., After years of restriction under the FDAs 503A Category 2 list, were now seeing momentum toward re evaluation and potential reintroduction FDA Peptide Reclassification 2026: What It Means for Providers The FDA just changed the rules on peptides effective April 15, 2026. BPC 157, GHK Cu, MOTS C, and TB 500 have been removed from the Category 2 restricted compounding list. Here is what FDA Peptide Update: Category 2 Removals Explained